Nisa Investment Advisors LLC Purchases 5,890 Shares of Monsanto Co. (MON)
Nisa Investment Advisors LLC boosted its position in Monsanto Co. (NYSE:MON) by 3.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,692 shares of the company’s stock after buying an additional 5,890 shares during the period. Nisa Investment Advisors LLC’s holdings in Monsanto were worth $19,616,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in MON. Virginia Retirement System purchased a new position in shares of Monsanto during the first quarter worth $626,000. Los Angeles Capital Management & Equity Research Inc. raised its position in shares of Monsanto by 472.2% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 144,058 shares of the company’s stock worth $12,640,000 after buying an additional 118,881 shares during the period. TIAA CREF Investment Management LLC raised its position in shares of Monsanto by 34.0% in the first quarter. TIAA CREF Investment Management LLC now owns 3,097,818 shares of the company’s stock worth $271,803,000 after buying an additional 786,058 shares during the period. Teachers Advisors Inc. raised its position in shares of Monsanto by 7.0% in the first quarter. Teachers Advisors Inc. now owns 1,236,482 shares of the company’s stock worth $108,489,000 after buying an additional 81,007 shares during the period. Finally, Stratos Wealth Partners LTD. raised its position in shares of Monsanto by 11.2% in the first quarter. Stratos Wealth Partners LTD. now owns 18,906 shares of the company’s stock worth $1,659,000 after buying an additional 1,908 shares during the period. Institutional investors own 79.06% of the company’s stock.
Shares of Monsanto Co. (NYSE:MON) traded up 0.40% during mid-day trading on Friday, reaching $102.20. The company had a trading volume of 3,664,539 shares. The firm has a 50-day moving average of $105.13 and a 200-day moving average of $101.01. The company has a market capitalization of $44.72 billion, a P/E ratio of 44.98 and a beta of 1.24. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 29th. The company reported $2.17 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.40 by $0.23. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.49 billion. During the same period last year, the business posted $2.39 earnings per share. The firm’s quarterly revenue was down 8.5% compared to the same quarter last year. On average, equities analysts anticipate that Monsanto Co. will post $4.46 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.11%. Monsanto’s dividend payout ratio (DPR) is currently 89.26%.
MON has been the topic of a number of recent research reports. Sanford C. Bernstein upgraded Monsanto from an “underperform” rating to a “market perform” rating and raised their price objective for the stock from $82.81 to $105.00 in a research note on Monday, September 26th. Goldman Sachs Group Inc. set a $92.00 price objective on Monsanto and gave the stock a “sell” rating in a research note on Monday, June 27th. Jefferies Group restated a “buy” rating on shares of Monsanto in a research note on Tuesday, September 6th. Citigroup Inc. raised their price objective on Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. Finally, Piper Jaffray Cos. restated an “overweight” rating and set a $127.00 price objective (up previously from $95.00) on shares of Monsanto in a research note on Monday, June 13th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $114.31.
In other news, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.